PHARMACEUTICAL COMPOSITON CONTAINING 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE ISETHIONATE FOR THE TREATMENT AND PREVENTION OF DEPENDENCE; TOLERANCE AND SENSITIZATION OF DRUGS

오피오이드, 중추 신경계 억제제, 정신 자극제 또는 니코틴과 같은 의존성 유발제에 대한(a)의존성을 방지 또는 감소시키고,(b)내성 또는 역 내성을 방지 또는 감소시키는 활성을 지닌 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 및 이의 약학적 및 수의학적으로 허용 가능한 염. PCT No. PCT/GB93/01243 Sec. 371 Date Dec. 6, 1994 Sec. 102(e) Date Dec. 6, 1994 PCT Filed Jun. 11, 1993 PCT Pub. No. WO93/25207 PCT Pub...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	NAKAMURA-CRAIG, MEIRE
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	NAKAMURA-CRAIG, MEIRE
description	오피오이드, 중추 신경계 억제제, 정신 자극제 또는 니코틴과 같은 의존성 유발제에 대한(a)의존성을 방지 또는 감소시키고,(b)내성 또는 역 내성을 방지 또는 감소시키는 활성을 지닌 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 및 이의 약학적 및 수의학적으로 허용 가능한 염. PCT No. PCT/GB93/01243 Sec. 371 Date Dec. 6, 1994 Sec. 102(e) Date Dec. 6, 1994 PCT Filed Jun. 11, 1993 PCT Pub. No. WO93/25207 PCT Pub. Date Dec. 23, 19933,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable salts have activity in (a) preventing or reducing dependence on, and (b) preventing or reducing tolerance or reverse tolerance to, a dependence inducing agent such as an opioid, a central nervous system depressant, a psychostimulant or nicotine.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR100268823BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR100268823BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR100268823BB13</originalsourceid><addsrcrecordid>eNqNzsFKw0AQxvFcPIj6DgNeFLLQJFoKnqabSXcwmVk2U8FeSpH1JFqo7-bruYh49jT_gd_hO6--YsA0oaetsccRvE5RZzaVkmLIwrKBrr53PePEom7pbtq6K68PoyaNgeR5vHVN3dZ3zhLjjoWAZ7LAKmgEgyawQGCJ0CYSA5QeYqKn0sWADtBTJOlJPD2A6UgJS_64maTs4R3-0bTdzJfV2evh7ZSvfu9FdT2Q-eDy8WOfT8fDS37Pn_vH1CwW7XK1arv1uun-p74BgGlLeQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITON CONTAINING 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE ISETHIONATE FOR THE TREATMENT AND PREVENTION OF DEPENDENCE; TOLERANCE AND SENSITIZATION OF DRUGS</title><source>esp@cenet</source><creator>NAKAMURA-CRAIG, MEIRE</creator><creatorcontrib>NAKAMURA-CRAIG, MEIRE</creatorcontrib><description>오피오이드, 중추 신경계 억제제, 정신 자극제 또는 니코틴과 같은 의존성 유발제에 대한(a)의존성을 방지 또는 감소시키고,(b)내성 또는 역 내성을 방지 또는 감소시키는 활성을 지닌 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 및 이의 약학적 및 수의학적으로 허용 가능한 염. PCT No. PCT/GB93/01243 Sec. 371 Date Dec. 6, 1994 Sec. 102(e) Date Dec. 6, 1994 PCT Filed Jun. 11, 1993 PCT Pub. No. WO93/25207 PCT Pub. Date Dec. 23, 19933,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable salts have activity in (a) preventing or reducing dependence on, and (b) preventing or reducing tolerance or reverse tolerance to, a dependence inducing agent such as an opioid, a central nervous system depressant, a psychostimulant or nicotine.</description><edition>7</edition><language>eng ; kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20001201&DB=EPODOC&CC=KR&NR=100268823B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20001201&DB=EPODOC&CC=KR&NR=100268823B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NAKAMURA-CRAIG, MEIRE</creatorcontrib><title>PHARMACEUTICAL COMPOSITON CONTAINING 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE ISETHIONATE FOR THE TREATMENT AND PREVENTION OF DEPENDENCE; TOLERANCE AND SENSITIZATION OF DRUGS</title><description>오피오이드, 중추 신경계 억제제, 정신 자극제 또는 니코틴과 같은 의존성 유발제에 대한(a)의존성을 방지 또는 감소시키고,(b)내성 또는 역 내성을 방지 또는 감소시키는 활성을 지닌 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 및 이의 약학적 및 수의학적으로 허용 가능한 염. PCT No. PCT/GB93/01243 Sec. 371 Date Dec. 6, 1994 Sec. 102(e) Date Dec. 6, 1994 PCT Filed Jun. 11, 1993 PCT Pub. No. WO93/25207 PCT Pub. Date Dec. 23, 19933,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable salts have activity in (a) preventing or reducing dependence on, and (b) preventing or reducing tolerance or reverse tolerance to, a dependence inducing agent such as an opioid, a central nervous system depressant, a psychostimulant or nicotine.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzsFKw0AQxvFcPIj6DgNeFLLQJFoKnqabSXcwmVk2U8FeSpH1JFqo7-bruYh49jT_gd_hO6--YsA0oaetsccRvE5RZzaVkmLIwrKBrr53PePEom7pbtq6K68PoyaNgeR5vHVN3dZ3zhLjjoWAZ7LAKmgEgyawQGCJ0CYSA5QeYqKn0sWADtBTJOlJPD2A6UgJS_64maTs4R3-0bTdzJfV2evh7ZSvfu9FdT2Q-eDy8WOfT8fDS37Pn_vH1CwW7XK1arv1uun-p74BgGlLeQ</recordid><startdate>20001201</startdate><enddate>20001201</enddate><creator>NAKAMURA-CRAIG, MEIRE</creator><scope>EVB</scope></search><sort><creationdate>20001201</creationdate><title>PHARMACEUTICAL COMPOSITON CONTAINING 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE ISETHIONATE FOR THE TREATMENT AND PREVENTION OF DEPENDENCE; TOLERANCE AND SENSITIZATION OF DRUGS</title><author>NAKAMURA-CRAIG, MEIRE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR100268823BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2000</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NAKAMURA-CRAIG, MEIRE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NAKAMURA-CRAIG, MEIRE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITON CONTAINING 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE ISETHIONATE FOR THE TREATMENT AND PREVENTION OF DEPENDENCE; TOLERANCE AND SENSITIZATION OF DRUGS</title><date>2000-12-01</date><risdate>2000</risdate><abstract>오피오이드, 중추 신경계 억제제, 정신 자극제 또는 니코틴과 같은 의존성 유발제에 대한(a)의존성을 방지 또는 감소시키고,(b)내성 또는 역 내성을 방지 또는 감소시키는 활성을 지닌 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 및 이의 약학적 및 수의학적으로 허용 가능한 염. PCT No. PCT/GB93/01243 Sec. 371 Date Dec. 6, 1994 Sec. 102(e) Date Dec. 6, 1994 PCT Filed Jun. 11, 1993 PCT Pub. No. WO93/25207 PCT Pub. Date Dec. 23, 19933,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable salts have activity in (a) preventing or reducing dependence on, and (b) preventing or reducing tolerance or reverse tolerance to, a dependence inducing agent such as an opioid, a central nervous system depressant, a psychostimulant or nicotine.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; kor
recordid	cdi_epo_espacenet_KR100268823BB1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	PHARMACEUTICAL COMPOSITON CONTAINING 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE ISETHIONATE FOR THE TREATMENT AND PREVENTION OF DEPENDENCE; TOLERANCE AND SENSITIZATION OF DRUGS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A30%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NAKAMURA-CRAIG,%20MEIRE&rft.date=2000-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR100268823BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true